Literature DB >> 22789058

Hepatocyte transplantation for inherited metabolic diseases of the liver.

C Jorns1, E C Ellis, G Nowak, B Fischler, A Nemeth, S C Strom, B G Ericzon.   

Abstract

Inherited metabolic diseases of the liver are characterized by deficiency of a hepatic enzyme or protein often resulting in life-threatening disease. The remaining liver function is usually normal. For most patients, treatment consists of supportive therapy, and the only curative option is liver transplantation. Hepatocyte transplantation is a promising therapy for patients with inherited metabolic liver diseases, which offers a less invasive and fully reversible approach. Procedure-related complications are rare. Here, we review the experience of hepatocyte transplantation for metabolic liver diseases and discuss the major obstacles that need to be overcome to establish hepatocyte transplantation as a reliable treatment option in the clinic.
© 2012 The Association for the Publication of the Journal of Internal Medicine.

Entities:  

Mesh:

Year:  2012        PMID: 22789058     DOI: 10.1111/j.1365-2796.2012.02574.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  39 in total

1.  Improvement of Infusion Process in Cell Transplantation: Effect of Shear Stress on Hepatocyte Viability Under Horizontal and Vertical Syringe Orientation.

Authors:  Sandi Sufiandi; Hiromichi Obara; Shin Enosawa; Huai-Che Hsu; Naoto Matsuno; Hiroshi Mizunuma
Journal:  Cell Med       Date:  2014-12-12

Review 2.  Enzyme Development for Human Islet Isolation: Five Decades of Progress or Stagnation?

Authors:  Daniel Brandhorst; Heide Brandhorst; Paul R V Johnson
Journal:  Rev Diabet Stud       Date:  2017-06-12

Review 3.  Concise Review: Updated Advances and Current Challenges in Cell Therapy for Inborn Liver Metabolic Defects.

Authors:  Mustapha Najimi; Florence Defresne; Etienne M Sokal
Journal:  Stem Cells Transl Med       Date:  2016-05-31       Impact factor: 6.940

Review 4.  Assessing the therapeutic potential of lab-made hepatocytes.

Authors:  Milad Rezvani; Andrew A Grimm; Holger Willenbring
Journal:  Hepatology       Date:  2016-05-26       Impact factor: 17.425

5.  Human liver stem/progenitor cells decrease serum bilirubin in hyperbilirubinemic Gunn rat.

Authors:  Cédric Maerckx; Tatiana Tondreau; Silvia Berardis; Jos van Pelt; Mustapha Najimi; Etienne Sokal
Journal:  World J Gastroenterol       Date:  2014-08-14       Impact factor: 5.742

6.  Macroporous Dual-compartment Hydrogels for Minimally Invasive Transplantation of Primary Human Hepatocytes.

Authors:  Nailah Seale; Suvasini Ramaswamy; Yu-Ru Shih; Inder Verma; Shyni Varghese
Journal:  Transplantation       Date:  2018-09       Impact factor: 4.939

Review 7.  Emerging advancements in liver regeneration and organogenesis as tools for liver replacement.

Authors:  Stacey S Huppert; Kathleen M Campbell
Journal:  Curr Opin Organ Transplant       Date:  2016-12       Impact factor: 2.640

8.  Curative ex vivo liver-directed gene therapy in a pig model of hereditary tyrosinemia type 1.

Authors:  Raymond D Hickey; Shennen A Mao; Jaime Glorioso; Faysal Elgilani; Bruce Amiot; Harvey Chen; Piero Rinaldo; Ronald Marler; Huailei Jiang; Timothy R DeGrado; Lukkana Suksanpaisan; Michael K O'Connor; Brittany L Freeman; Samar H Ibrahim; Kah Whye Peng; Cary O Harding; Chak-Sum Ho; Markus Grompe; Yasuhiro Ikeda; Joseph B Lillegard; Stephen J Russell; Scott L Nyberg
Journal:  Sci Transl Med       Date:  2016-07-27       Impact factor: 17.956

9.  Control of IBMIR Induced by Fresh and Cryopreserved Hepatocytes by Low Molecular Weight Dextran Sulfate Versus Heparin.

Authors:  Elisabet Gustafson; Sana Asif; Huda Kozarcanin; Graciela Elgue; Staffan Meurling; Kristina N Ekdahl; Bo Nilsson
Journal:  Cell Transplant       Date:  2016-07-22       Impact factor: 4.064

10.  Liver engraftment and repopulation by in vitro expanded adult derived human liver stem cells in a child with ornithine carbamoyltransferase deficiency.

Authors:  Etienne M Sokal; Xavier Stéphenne; Chris Ottolenghi; Nawal Jazouli; Philippe Clapuyt; Florence Lacaille; Mustapha Najimi; Pascale de Lonlay; Françoise Smets
Journal:  JIMD Rep       Date:  2013-10-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.